Why is warfarin underutilized in patients with atrial fibrillation?

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Volumn 10 Suppl 1, Issue , 2004, Pages 21-25

  Flaker, Greg C ^a   Schutz, John ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG UTILIZATION; HEART ATRIUM FIBRILLATION; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 3042785733     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JICE.0000011342.26830.5f     Document Type: Review

References (39)